Teva Pharmaceutical Industries (NYSE: TEVA)
Teva Pharmaceutical Industries Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Teva Pharmaceutical Industries Company Info
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
News & Analysis
My Top 10 Portfolio Holdings for 2025
This combination of growth and value stocks has the potential to outperform the broader market in 2025 (and beyond).
3 Bargain Stocks to Buy on the Dip
These stocks should be poised to rebound.
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
It's unclear whether the pivot will be enough to halt its recent decline.
Why Teva Pharmaceutical Stock Is Jumping Today
Investors are reacting positively to Teva's new growth strategy.
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
There's more to the concept of safety than having a business model that looks safe.
Better Generics Pharmaceutical Stock: Teva or Viatris?
Both have plans to return to growth.
Why Teva Pharmaceutical Stock Is Sliding Today
Investors were disappointed with the drugmaker's 2023 outlook.
6 Great Stocks to Buy in 2023 and Hold Forever
I own all six great businesses and don't plan to sell a single share.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.